Metraipolis › archive › dc_1f88fb01ca0d

Potential Anti-Cancer Drug 6RK73 Suppresses Ovarian Cancer Growth by Inactivating the AKT1/Sp1 Induced c-Myc Signaling Pathway — Europe PMC PMID:41584043

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41584043
DOI
10.7150/jca.113511
License (as archived)
solo-consultazione
Archived
2026-11-07T03:43:42.332Z
SHA-256 of the archived text
e79822ea894718e39800483b58738ba26c6c6b2fca4cbe1a8fb7e846d932eb06
Stable URL of this page
https://metraipolis.com/documento/dc_1f88fb01ca0d

How to cite

Potential Anti-Cancer Drug 6RK73 Suppresses Ovarian Cancer Growth by Inactivating the AKT1/Sp1 Induced c-Myc Signaling Pathway — Europe PMC PMID:41584043 — Europe PMC (en), https://europepmc.org/article/MED/41584043 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1f88fb01ca0d (Metraipolis archive dc_1f88fb01ca0d, sha256 e79822ea894718e39800483b58738ba26c6c6b2fca4cbe1a8fb7e846d932eb06)
BibTeX
@misc{dc1f88fb01ca0d,
  title = {Potential Anti-Cancer Drug 6RK73 Suppresses Ovarian Cancer Growth by Inactivating the AKT1/Sp1 Induced c-Myc Signaling Pathway — Europe PMC PMID:41584043},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41584043},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1f88fb01ca0d; sha256 e79822ea894718e39800483b58738ba26c6c6b2fca4cbe1a8fb7e846d932eb06},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41584043. Agents can read the archived copy with the MCP tool read_document.